Close Menu

NEW YORK (GenomeWeb) – Abbott Laboratories attempted to terminate its pending merger with Alere, Alere said late on Thursday. 

The firm has twice delayed filing its 2015 earnings report, leading Abbott to inform Alere that "it has serious concerns about, among other things, the accuracy of various representations, warranties and covenants made by Alere in the parties' merger agreement," Alere said. Abbott even offered to pay Alere a termination fee of $30 million to $50 million to pay for Alere's transaction expenses.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.